Sort by
Refine Your Search
-
the development of new cancer therapies. Few UBE2N inhibitors have been described in the literature, and these are mainly covalent inhibitors, which, due to a lack of selectivity, expose patients
-
to develop the following research project : Reverse-engineered concrete formulations to evaluate the risk of Alkali-Silica Reaction in case of extended life Nuclear Power Plant This postdoctoral position is
Enter an email to receive alerts for development "https:" "https:" "https:" positions